During the month of October, all around the globe our employees gathered to learn and help spread awareness about Breast Cancer, a disease in which 1 in 8 women will be diagnosed with in 2022.*

This was a great opportunity for all of us to not only learn about the many myths and facts and the importance of early detection via self-exams or mammograms, but to raise money for breast cancer charities where we live and work.

No matter the location, all employees wore pink in solidarity, and submitted many photos to commemorate their commitment to this important cause. We are proud to continue our work in this important space in efforts to eradicate this disease so that friends, family, and those we don’t even know need not suffer.

Aixial Group and encapsia are delighted to donate a total of £1000 to breast cancer charities.

We remain committed to raising awareness and contributing to other disease awareness days around the world through staff events and making further charitable donations.

Thank you to all our employees who gathered in our global offices to help raise awareness!
*ACS, 2022; DeSantis et al., 2021


Cmed Czech Republic Office - breast cancer awareness monthCmed Denmark Office - breast cancer awareness monthCmed England Office - breast cancer awareness monthCmed France Office - breast cancer awareness monthCmed India Office - breast cancer awareness monthCmed Romania Office - breast cancer awareness monthCmed United States Office - breast cancer awareness month



Learn how encapsia can help you!

To book a no-obligation meeting or demonstration please get in touch by using the contact form below:

Contact us

Latest articles

Delayed Clinical Data and Its Impact

The increasing complexity of modern trials demands more intensive data capture. Innovative study designs seek to minimize patient exposure to potential risks, improve convenience and shorten therapy time-to-market —requiring collecting and assimilating more data points than ever before. Data now…

Read article

Five benefits of virtual clinical trials

Clinical trials are slow, costly, and inefficient. Different studies put the average cost of drug development at $1.3 to $2.8 billion— with clinical trials accounting for about two-thirds.  Traditional trials burden patients with financial and time-costly travel requirements. On average,…

Read article

Clinical trial platform provider encapsia welcomes new COO

Clinical trial management solutions provider, encapsia, has announced the appointment of Francis Destin as its new Chief Operating Officer. Francis brings more than 20 years of expertise to the role, specializing in the management of data-related projects in clinical trials…

Read article